Prosecution Insights
Last updated: October 26, 2026

Amanda L Zink, USPTO Patent Examiner

Listed by the USPTO as ZINK, AMANDA L

Tech Center 3700 • Art Units: 3739 3773 3794

This examiner grants 85% of resolved cases

Analysis

ZINK, AMANDA L is assigned to Tech Center 3700 and Art Unit 3739. The record includes 681 resolved cases and an allowance rate of 85.2%. The median time to allowance is 1212 days, so applicants should account for a lengthy timing interval even alongside the stated allowance outcome.

The interview lift is 3.1%, indicating a limited association with allowance outcomes. Practitioners may therefore emphasize claim quality and written prosecution strategy, using interviews selectively for targeted clarification. The represented companies are Medtronic Ireland Manufacturing Unlimited Company, Covidien L.P., and Cilag GmbH International. The listed firms are 24IP LAW GROUP USA, PLLC, Clayton, McKay & Bailey, PC, and FREDRIKSON & BYRON, P.A.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

85.2%
Allow Rate
+15.2% vs TC avg
698
Total Applications
+3.1%
Interview Lift
1212
Avg Prosecution Days
Based on 681 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
27.9%
§102 Novelty
41.6%
§103 Obviousness
9.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18844457 SURGICAL SMOKE FILTERING DEVICE Non-Final OA Covidien LP
18131138 METHODS FOR OPERATING GENERATOR FOR DIGITALLY GENERATING ELECTRICAL SIGNAL WAVEFORMS AND SURGICAL INSTRUMENTS Final Rejection Cilag GmbH International
18351120 Cryoablation Devices And Related Methods Non-Final OA Regents of the University of California
18507558 MEDICAL INSTRUMENT WITH MECHANICAL INTERLOCK Non-Final OA Auris Health, Inc.
18399810 NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES Non-Final OA Medtronic Ireland Manufacturing Unlimited Company
18399817 NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES Non-Final OA Medtronic Ireland Manufacturing Unlimited Company
17971762 POSITION TRACKING FOR PULSED FIELD ABLATION Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amanda L Zink's allowance rate?

85.2% of resolved applications examined by Amanda L Zink were allowed (681 resolved cases), compared with 0.0% across Art Unit 3739 over the last five years.

Does an interview help with examiner Amanda L Zink?

This examiner's interview lift is +3.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amanda L Zink take to allow a patent?

Applications allowed by Amanda L Zink took 1,212 days on average from filing to allowance.

Which art unit does examiner Amanda L Zink work in?

Amanda L Zink examines applications in Art Unit 3739 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month